Recent
quick returnPopular searches
live pathsNASDAQ · HEALTHCARE · Earnings & dividends
Next scheduled report in 64 days, last quarterly EPS, consensus estimates, payout status, and capital-return context for AMGN.
| Period | Actual EPS | Est. EPS | Surprise |
|---|---|---|---|
| Q1 | $0.13 | $0.13 | +0.0% |
| Q2 | $0.16 | $0.15 | +6.7% |
| Q3 | $0.16 | $0.15 | +6.7% |
| Q4 | $0.16 | $0.16 | +0.0% |
| Q1 | $0.16 | $0.16 | +0.0% |
| Q2 | $0.18 | $0.18 | +0.0% |
| Q3 | $0.17 | $0.17 | +0.0% |
| Q4 | $0.17 | $0.17 | +0.0% |
Most recent periods shown. Full history available via data providers.
Dividends and capital return
Dividend yield only makes sense next to earnings power. TECHi keeps payout ratio, yield, and ex-date on this page so income investors can read the cash return against EPS.
EPS beat history
Recent reported quarters are compared against the consensus estimate so the latest print is easy to read at a glance. Positive bars mean reported EPS cleared expectations; negative bars mark misses.
Recent quarters
$5.15 actual vs $4.77 est.
$5.29 actual vs $4.73 est.
$5.64 actual vs $5.01 est.
$2.65 actual vs $3.12 est.
$4.90 actual vs $4.26 est.
$5.31 actual vs $5.08 est.
Earnings call transcript
12 segments
Operator
Operator
My name is Julianne, and I will be your conference facilitator today for the Amgen Inc. Q1 2026 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. There will be a question and answer session at the conclusion of the...
Casey Capparelli
Vice President, Investor Relations
Thank you, Julianne. Good afternoon, everyone, and welcome to our 2026 earnings call. Robert A. Bradway will lead the call today and be followed by a broader review of our performance by Murdo Gordon, James E. Bradner, and Peter H. Griffith. Through the course...
Robert A. Bradway
Chairman and CEO
Good afternoon, and thank you for joining us. We had a strong first quarter and are well positioned to achieve our objectives for the year. Recall, we previously described 2026 as a springboard year for Amgen Inc., a year in which we expect our rapidly growing...
Murdo Gordon
Executive Vice President, Worldwide Commercial
Thanks, Bob. As mentioned, in 2026, 16 products achieved double-digit or better sales growth and 17 products are now annualizing at sales of $1 billion or more. Overall, we delivered 4% growth in product sales driven by a diversified portfolio of fast-growing...
James E. Bradner
President, Research & Development and Head of AI & Data Initiatives
Thank you, Murdo, and good afternoon, everyone. Let me begin with Meritide, a new paradigm in the management of obesity, obesity-related conditions, and type 2 diabetes. The unique antibody-peptide conjugate design of Meritide delivers a potential for strong...
Peter H. Griffith
Executive Vice President & Chief Financial Officer
Thank you, Jay. We are pleased with our strong first quarter performance, executing through a full quarter of the patent expirations and losses of exclusivity. Our non-GAAP operating margin was 45%. We continue to invest in advancing our pipeline with non-GAAP...
Earnings desk view
Amgen Inc has per-quarter EPS history available across recent reports, pairing the latest actual EPS with consensus estimates and valuation context. For real-time commentary on AMGN's next print, the news archive tracks every editorial reaction to earnings reports.
Payout history
Market data feed
| Ex-date | Amount | Record date | Payment date |
|---|---|---|---|
| $2.52 | |||
| $2.52 | |||
| $2.38 | |||
| $2.38 | |||
| $2.38 | |||
| $2.38 | |||
| $2.25 | |||
| $2.25 | |||
| $2.25 | |||
| $2.25 | |||
| $2.13 | |||
| $2.13 | |||
| $2.13 | |||
| $2.13 | |||
| $1.94 | |||
| $1.94 | |||
| $1.94 | |||
| $1.94 | |||
| $1.76 | |||
| $1.76 | |||
| $1.76 | |||
| $1.76 | |||
| $1.60 | — | — | |
| $1.60 |
Dividend safety read
A payout ratio in this band gives the dividend room to grow even if earnings dip. Watch quarterly cash-flow coverage to confirm the buffer holds.
Frequently asked
Amgen Inc reports quarterly. Track the latest scheduled date and consensus estimate on TECHi's AMGN earnings page — updated whenever the company confirms the quarterly call.
Amgen Inc's trailing earnings per share is approximately $14.38 based on the most recent fundamentals snapshot.
TECHi's AMGN earnings page covers the next scheduled report, the last several quarters of beats and misses, and editorial commentary tied to each release.
Beat / miss commentary for the most recent Amgen Inc quarter is published on the TECHi AMGN earnings page. Subscribe to the markets newsletter for the morning brief on every print.
Yes — Amgen Inc (AMGN) pays a dividend with a current yield of approximately 2.87%.
Amgen Inc has a forward dividend yield of approximately 2.87% based on the most recent quote.
Amgen Inc distributes approximately $9.80 per share annually based on the latest declared payout.
Amgen Inc's payout ratio is approximately 68.15%, the share of earnings paid out as dividends. A lower ratio leaves more room for dividend growth.
TECHi's AMGN earnings and dividends page shows the live yield, payout history, ex-dividend dates, payout ratio, and dividend-safety commentary beside EPS history.
